Dr. Shanahan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2222 E NC Highway 54
Ste 200
Durham, NC 27713Phone+1 919-405-2040Fax+1 919-405-2266
Education & Training
Duke University HospitalFellowship, Rheumatology, 2000 - 2002- Duke University HospitalResidency, Internal Medicine, 1997 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1997
Certifications & Licensure
NC State Medical License 1998 - 2025
NJ State Medical License 2003 - 2005
AL State Medical License 2002 - 2004
PA State Medical License 2003 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
- A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
- Join now to see all
Publications & Presentations
PubMed
- 877 citationsEfficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus...Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace, Joseph C. Shanahan, Kevin Latinis
Arthritis and Rheumatism. 2010-01-01 - 679 citationsMycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisGerald B. Appel, Gabriel Contreras, Mary Anne Dooley, Ellen M. Ginzler, David A. Isenberg
Journal of the American Society of Nephrology. 2009-05-01 - 68 citationsMQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.Lorinda Chung, Lee Shapiro, David Fiorentino, Murray Baron, Joseph C. Shanahan
Arthritis and Rheumatism. 2009-03-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
